Skip to main content

Incyte to Present at Upcoming Investor Conferences

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September:

  • Cantor Global Healthcare Conference on Wednesday, September 3, 2025 at 8:00 am (EDT)
  • Well Fargo Healthcare Conference on Thursday, September 4, 2025 at 8:45 am (EDT)
  • Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 at 10:00 am (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  257.75
-8.91 (-3.34%)
AAPL  352.78
-3.49 (-0.98%)
AMD  504.28
-29.78 (-5.58%)
BAC  50.08
-0.94 (-1.84%)
GOOG  281.26
-11.26 (-3.85%)
META  626.41
-15.28 (-2.38%)
MSFT  517.99
-5.89 (-1.12%)
NVDA  156.14
-6.71 (-4.12%)
ORCL  119.09
-6.26 (-4.99%)
TSLA  379.74
-10.48 (-2.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.